• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Interlinked Pathophysiology and Integrated Management Approach.心血管-肾脏-肝脏-代谢综合征:相互关联的病理生理学与综合管理方法
Cureus. 2025 Jun 11;17(6):e85813. doi: 10.7759/cureus.85813. eCollection 2025 Jun.
2
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
3
Systemic Inflammatory Response Syndrome全身炎症反应综合征
4
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.临床实践更新:美国胃肠病学会关于可弯曲性埃勒斯-当洛综合征的胃肠道表现及自主神经或免疫功能障碍的临床实践更新:专家综述
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.
5
Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis.代谢功能障碍相关脂肪性肝病与心房颤动:发病机制综述
World J Cardiol. 2025 Jun 26;17(6):106147. doi: 10.4330/wjc.v17.i6.106147.
6
Isolated Methylmalonic Acidemia孤立性甲基丙二酸血症
7
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.超声检查在酒精性肝病患者中对酒精性肝硬化的诊断作用
Cochrane Database Syst Rev. 2016 Mar 2;3(3):CD011602. doi: 10.1002/14651858.CD011602.pub2.
8
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

本文引用的文献

1
Cardiovascular-Kidney-Metabolic Syndrome: A New Paradigm in Clinical Medicine or Going Back to Basics?心血管-肾脏-代谢综合征:临床医学的新范式还是回归基础?
J Clin Med. 2025 Apr 19;14(8):2833. doi: 10.3390/jcm14082833.
2
From Metabolic Syndrome to Cardio-Kidney-Metabolic Syndrome in the SIMETAP Study: Prevalence Rates of Metabolic Syndrome and Its Independent Associations with Cardio-Renal-Metabolic Disorders Other than Its Defining Criteria.在SIMETAP研究中从代谢综合征到心肾代谢综合征:代谢综合征的患病率及其与除定义标准外的心肾代谢紊乱的独立关联
Biomedicines. 2025 Feb 28;13(3):590. doi: 10.3390/biomedicines13030590.
3
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review.心血管、肾脏及代谢紊乱中的蛋白尿:最新综述
Circulation. 2025 Mar 11;151(10):716-732. doi: 10.1161/CIRCULATIONAHA.124.071079. Epub 2025 Mar 10.
4
From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework.从心血管-肾脏-代谢综合征到心血管-肾脏-肝脏-代谢综合征:提出一个扩展框架。
Biomolecules. 2025 Feb 2;15(2):213. doi: 10.3390/biom15020213.
5
Exploring the role of curcumin in mitigating oxidative stress to alleviate lipid metabolism disorders.探索姜黄素在减轻氧化应激以缓解脂质代谢紊乱中的作用。
Front Pharmacol. 2025 Jan 30;16:1517174. doi: 10.3389/fphar.2025.1517174. eCollection 2025.
6
Updated evidence on cardiovascular and renal effects of GLP-1 receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives.GLP-1 受体激动剂和 SGLT2 抑制剂及非奈利酮联合治疗的心血管和肾脏效应的更新证据:叙述性评价和观点。
Cardiovasc Diabetol. 2024 Nov 15;23(1):410. doi: 10.1186/s12933-024-02500-y.
7
Causal Links Between Renal Function and Cardiac Structure, Function, and Disease Risk.肾功能与心脏结构、功能和疾病风险之间的因果关系。
Glob Heart. 2024 Nov 6;19(1):83. doi: 10.5334/gh.1366. eCollection 2024.
8
Cardiovascular-kidney-metabolic syndrome - An integrative review.心血管-肾脏-代谢综合征——一项综合综述。
Prog Cardiovasc Dis. 2024 Nov-Dec;87:26-36. doi: 10.1016/j.pcad.2024.10.012. Epub 2024 Oct 30.
9
ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于心血管结局的一级和二级预防:2024年埃及心脏病学专家共识与CVREP基金会合作发布的建议
Cardiol Ther. 2024 Dec;13(4):707-736. doi: 10.1007/s40119-024-00381-6. Epub 2024 Oct 25.
10
Mendelian randomization study of sodium-glucose cotransporter 2 inhibitors in cardiac and renal diseases.基于孟德尔随机化的钠-葡萄糖协同转运蛋白 2 抑制剂在心脏和肾脏疾病中的研究。
J Int Med Res. 2024 Aug;52(8):3000605241272639. doi: 10.1177/03000605241272639.

心血管-肾脏-肝脏-代谢综合征:相互关联的病理生理学与综合管理方法

Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Interlinked Pathophysiology and Integrated Management Approach.

作者信息

Arragan Lezama Carlos Alejandro, Jaramillo Ramos Julio Joel, Armas Eguizábal David Alejandro, Solares Ovando Ximena Sofía, Minera Villagrán Julio Cesar, Males Caiza Cinthya Jhoana

机构信息

General Practice, Universidad Anáhuac Xalapa, Veracruz, MEX.

Internal Medicine, Hospital Santo Tomás, Panama City, PAN.

出版信息

Cureus. 2025 Jun 11;17(6):e85813. doi: 10.7759/cureus.85813. eCollection 2025 Jun.

DOI:10.7759/cureus.85813
PMID:40662045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12257864/
Abstract

Interdisciplinary research has revealed that heart, kidney, liver, and metabolic diseases share interlinked pathological mechanisms, including inflammation, oxidative stress, insulin resistance, and endothelial health issues. However, integrated care for these diseases is challenging due to different symptoms, diagnostic rules, and treatment options. The review aims to study the common mechanisms behind cardiovascular-renal-hepatic-metabolic syndrome and explore ways to coordinate management. When these systems work poorly together, damage can form a vicious cycle, increasing hypertension, chronic kidney disease, non-alcoholic fatty liver disease, and metabolic syndrome. Changes in medicine, daily lifestyle, and drugs can interrupt the pathological cascade. However, clinical practice is hindered by patient presentations, lack of teamwork across healthcare specialties, and incomplete therapy plans. Gut-organ axis dysfunction and inflammation play a significant role in multiple organ diseases, and prompt risk assessment and early intervention can prevent heart damage.

摘要

跨学科研究表明,心脏、肾脏、肝脏和代谢性疾病存在相互关联的病理机制,包括炎症、氧化应激、胰岛素抵抗和内皮健康问题。然而,由于这些疾病的症状、诊断规则和治疗方案不同,对其进行综合护理具有挑战性。本综述旨在研究心血管-肾脏-肝脏-代谢综合征背后的共同机制,并探索协调管理的方法。当这些系统协同工作不佳时,损害会形成恶性循环,增加高血压、慢性肾脏病、非酒精性脂肪性肝病和代谢综合征的发生风险。医学、日常生活方式和药物的改变可以中断病理级联反应。然而,患者的临床表现、医疗各专科之间缺乏团队合作以及治疗计划不完整阻碍了临床实践。肠道-器官轴功能障碍和炎症在多种器官疾病中起重要作用,及时的风险评估和早期干预可以预防心脏损害。